DrugPatentWatch

DrugPatentWatch Archives

You are currently viewing the 2009 archives
Click here to return to the current data set

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Tradename: SYNTHROID

Summary for Tradename: SYNTHROID

Patents:0
Applicants:1
NDAs:1
Suppliers: see list8
2013 Sales:$858,725,000
drug
patent expirations by year for
 SYNTHROID

Pharmacology for Tradename: SYNTHROID

Ingredient-typeThyroxine
Drug Classl-Thyroxine

Clinical Trials for: SYNTHROID

Fasting Study of Levothyroxine Sodium Tablets 200 mg to Synthroid Tablets 200 mg
Status: Completed Condition: Healthy

Fasting Study of Levothyroxine Sodium Tablets 300 μg to Synthroid® Tablets 300 μg
Status: Completed Condition: Healthy

Fasting Study of Levothyroxine Sodium Tablets 300 Mcg to Synthroid® Tablets 300 Mcg
Status: Completed Condition: Healthy

Thyroid Hormone Dose Adjustment in Pregnancy
Status: Recruiting Condition: Pregnancy; Hypothyroidism

Bioequivalence of Two Levothyroxine Tablet Formulations in Healthy Indian Volunteers
Status: Completed Condition: Hypothyroidism

Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors
Status: Terminated Condition: Hypothyroidism; Brain Tumor

Study of Optimal Replacement of Thyroxine in the Elderly
Status: Recruiting Condition: Hypothyroidism

Fasting Study of Levothyroxine Sodium Tablets 300 μg to Levothroid® Tablets 300 μg
Status: Completed Condition: Healthy

Bioavailability Investigations of Thyronajod Mite Tablets of Dosage Strengths 50 μg Levothyrox-ine/75 μg Iodine, and 100 μg Levothyroxine/75 μg Iodine vs. a Levothyroxine Drinking-Solution: A Randomised Cross Over Study in Healthy Male Individuals. Currently: 50 μg/ 75 μg Tablets
Status: Completed Condition: Pharmacokinetics

Combined Therapy With L-Thyroxine and L-Triiodothyronine Compared to L-Thyroxine Alone
Status: Completed Condition: Hypothyroidism

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott
SYNTHROID
levothyroxine sodium
TABLET; ORAL021402Jul 24, 2002RXNo<disabled><disabled>
Abbott
SYNTHROID
levothyroxine sodium
TABLET; ORAL021402Jul 24, 2002RXYes<disabled><disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc